Cardiome Pharma Corporation - O CRME
39.21 +0.49 (+1.27%)
At closeJun 28, 2019, 6:07 PM EDT
38.13 Day range 38.13
52-week range unavailable
- YTD
- -100.00%
- 1 year
- -100.00%
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 21, 2016 | Leerink Swann | Initiated | — | Outperform |
| Oct 11, 2016 | Mackie Research | Downgrade | — | Hold |
| May 31, 2016 | H.C. Wainwright | Initiated | — | Buy |
| May 5, 2016 | Mackie Research | Upgrade | — | Speculative Buy |
| Mar 8, 2015 | Mackie Research | Downgrade | — | Hold |
| Nov 17, 2014 | Laurentian Bank | Initiated | — | Buy |
| Jan 29, 2014 | Canaccord Genuity | Downgrade | — | — |
| Dec 9, 2013 | Cormark Securities | Initiated | — | Speculative Buy |
| Jul 24, 2013 | Euro Pacific Capital | Initiated | — | Hold |
| Nov 14, 2012 | Bloom Burton & Co. | Downgrade | — | Sell |
| Apr 10, 2012 | Bloom Burton & Co. | Upgrade | — | Hold |
| Mar 18, 2012 | Oppenheimer | Downgrade | — | Perform |